Intramyocardial delivery of injectable hydrogel with arctigenin alleviated myocardial ischemia–reperfusion injury in rats
Biotechnology and Applied Biochemistry · 2024
DOI: 10.1002/bab.2554 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, 2024. Verfasst von Chengyin Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Lignans, Furans, Rats, Sprague-Dawley, Hydrogels. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Yangzhou University, Elderly Health Research Project of Jiangsu Province.
Abstract (Originalsprache)
Arctigenin belongs to a major bioactive component of Fructus arctii and has been found with cardioprotective effects on rats with ischemia‒reperfusion (I/R) injury. The application of arctigenin is limited due to poor water solubility and low bioavailability. Hydrogel drug delivery systems can improve the efficacy and safety of drugs, increase drug utilization, and reduce side effects. We hypothesized that hydrogels containing arctigenin would facilitate the effect of arctigenin and alleviate I/R injury in the rat heart. Presently, adult Sprague–Dawley (SD) rats were subjected to 1 h of I/R injury, then hydrogels comprising arctigenin were implanted into the myocardium of rats. Triphenyl tetrazolium chloride staining, hematoxylin–eosin staining, and terminal deoxynucleotidyl transferase‐mediated dUTP nick end labeling staining and Western blot were performed for evaluating the infarct size, histopathological, and vital protein alterations of hearts. It was discovered that the hydrogel combined with arctigenin abated apoptosis and reduced infarct size. In addition, the results of echocardiography and Masson staining suggested that the hydrogel with arctigenin improved cardiac function, restrained myocardial fibrosis, and activated AMP‐activated protein kinase (AMPK) and sirtuin 1 (SIRT1). Collectively, the injectable hydrogel delivery system enhances the effect of arctigenin, which may play a protective role in I/R injury by activating AMPK and SIRT1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu, China.
- Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
ORCID-Profile: Xuejun Jiang
Förderung
- Yangzhou University
- Elderly Health Research Project of Jiangsu Province
Zitieren
APA
Liu, C., Jiang, X., Liang, L., Liu, H., Li, L., & Shan, Q. (2024). Intramyocardial delivery of injectable hydrogel with arctigenin alleviated myocardial ischemia–reperfusion injury in rats. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.2554
Vancouver
Liu C, Jiang X, Liang L, Liu H, Li L, Shan Q. Intramyocardial delivery of injectable hydrogel with arctigenin alleviated myocardial ischemia–reperfusion injury in rats. Biotechnology and Applied Biochemistry. 2024. doi:10.1002/bab.2554
BibTeX
@article{Liu2024,
author = {Liu, Chengyin and Jiang, Xuejun and Liang, Lanyu and Liu, Han and Li, Li and Shan, Qing},
title = {Intramyocardial delivery of injectable hydrogel with arctigenin alleviated myocardial ischemia–reperfusion injury in rats},
journal = {Biotechnology and Applied Biochemistry},
year = {2024},
doi = {10.1002/bab.2554}
}
EUVIMED